Subpart C - INDEX OF LEGALLY MARKETED UNAPPROVED NEW ANIMAL DRUGS FOR MINOR SPECIES
- Section 516.111 - Scope of this subpart
- Section 516.115 - Definitions
- Section 516.117 - Submission of correspondence under this subpart
- Section 516.119 - Permanent-resident U.S. agent for foreign requestors and holders
- Section 516.121 - Meetings
- Section 516.123 - Informal conferences regarding agency administrative actions
- Section 516.125 - Investigational use of minor species new animal drugs to support indexing
- Section 516.129 - Content and format of a request for determination of eligibility for indexing
- Section 516.131 - Refuse to file a request for determination of eligibility for indexing
- Section 516.133 - Denying a request for determination of eligibility for indexing
- Section 516.135 - Granting a request for determination of eligibility for indexing
- Section 516.137 - Notification of decision regarding eligibility for indexing
- Section 516.141 - Qualified expert panels
- Section 516.143 - Written report
- Section 516.145 - Content and format of a request for addition to the index
- Section 516.147 - Refuse to file a request for addition to the index
- Section 516.149 - Denying a request for addition to the index
- Section 516.151 - Granting a request for addition to the index
- Section 516.153 - Notification of decision regarding index listing
- Section 516.155 - Labeling of indexed drugs
- Section 516.157 - Publication of the index and content of an index listing
- Section 516.161 - Modifications to indexed drugs
- Section 516.163 - Change in ownership of an index file
- Section 516.165 - Records and reports
- Section 516.167 - Removal from the index
- Section 516.171 - Confidentiality of data and information in an index file